MA49588A - Composition pharmaceutique pour le traitement de l'anémie dans un récipient adapté, qui conserve les ingrédients actifs séparés selon une méthode scellée :complexe ferrique avec de la caséine n-acétyl-l-aspartique et folinate pentahydrate de calcium - Google Patents
Composition pharmaceutique pour le traitement de l'anémie dans un récipient adapté, qui conserve les ingrédients actifs séparés selon une méthode scellée :complexe ferrique avec de la caséine n-acétyl-l-aspartique et folinate pentahydrate de calciumInfo
- Publication number
- MA49588A MA49588A MA049588A MA49588A MA49588A MA 49588 A MA49588 A MA 49588A MA 049588 A MA049588 A MA 049588A MA 49588 A MA49588 A MA 49588A MA 49588 A MA49588 A MA 49588A
- Authority
- MA
- Morocco
- Prior art keywords
- pentahciumdrate
- calahciumdrate
- folinate
- anemia
- casein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20180100151A GR1009589B (el) | 2018-04-05 | 2018-04-05 | Φαρμακευτικο σκευασμα για την αντιμετωπιση της αναιμιας, σε καταλληλο περιεκτη, που διατηρει στεγανα διαχωρισμενα μεταξυ τους τα δραστικα συστατικα: συμπλοκο του τρισθενους σιδηρου με ν-ακετυλο-l-ασπαρτικη καζεϊνη και πενταϋδρικο φυλλινικο ασβεστιο |
Publications (2)
Publication Number | Publication Date |
---|---|
MA49588A true MA49588A (fr) | 2020-05-20 |
MA49588B1 MA49588B1 (fr) | 2023-08-31 |
Family
ID=66102020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA49588A MA49588B1 (fr) | 2018-04-05 | 2019-03-22 | Composition pharmaceutique pour le traitement de l'anémie dans un récipient adapté, qui conserve les ingrédients actifs séparés selon une méthode scellée :complexe ferrique avec de la caséine n-acétyl-l-aspartique et folinate pentahydrate de calcium |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP3549576B1 (fr) |
DK (1) | DK3549576T3 (fr) |
ES (1) | ES2949782T3 (fr) |
FI (1) | FI3549576T3 (fr) |
GR (1) | GR1009589B (fr) |
HR (1) | HRP20230688T1 (fr) |
HU (1) | HUE062623T2 (fr) |
LT (1) | LT3549576T (fr) |
MA (1) | MA49588B1 (fr) |
PL (1) | PL3549576T3 (fr) |
PT (1) | PT3549576T (fr) |
RS (1) | RS64344B1 (fr) |
SI (1) | SI3549576T1 (fr) |
SM (1) | SMT202300189T1 (fr) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4931441A (en) * | 1988-11-09 | 1990-06-05 | Luitpold Pharmaceuticals, Inc. | Stabilized aqueous leucovorin calcium compositions |
IT1237509B (it) * | 1989-10-31 | 1993-06-08 | Magis Farmaceutici | Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche |
ITMO20040200A1 (it) * | 2004-07-29 | 2004-10-29 | Biofer Spa | Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche. |
US20090035385A1 (en) * | 2004-12-22 | 2009-02-05 | Drugtech Corporation | Compositions including iron |
EP1790356A1 (fr) * | 2005-11-24 | 2007-05-30 | Vifor (International) Ag | Préparation contenant des complexes de fer(III) et des composés rédoxs |
ITTO20121006A1 (it) | 2012-11-20 | 2014-05-21 | Inge Spa | Dispositivo per la conservazione ermetica di una sostanza da miscelare ad un'altra contenuta in un contenitore. |
ES2655238T3 (es) * | 2014-12-19 | 2018-02-19 | Ioulia Tseti | Un proceso para producir complejos de caseína N-acetil-aspartilada y hierro (III) y uso de los mismos en composiciones farmacéuticas |
-
2018
- 2018-04-05 GR GR20180100151A patent/GR1009589B/el active IP Right Grant
-
2019
- 2019-03-22 SI SI201930567T patent/SI3549576T1/sl unknown
- 2019-03-22 PL PL19386015.2T patent/PL3549576T3/pl unknown
- 2019-03-22 LT LTEP19386015.2T patent/LT3549576T/lt unknown
- 2019-03-22 EP EP19386015.2A patent/EP3549576B1/fr active Active
- 2019-03-22 MA MA49588A patent/MA49588B1/fr unknown
- 2019-03-22 RS RS20230463A patent/RS64344B1/sr unknown
- 2019-03-22 SM SM20230189T patent/SMT202300189T1/it unknown
- 2019-03-22 ES ES19386015T patent/ES2949782T3/es active Active
- 2019-03-22 HU HUE19386015A patent/HUE062623T2/hu unknown
- 2019-03-22 FI FIEP19386015.2T patent/FI3549576T3/fi active
- 2019-03-22 PT PT193860152T patent/PT3549576T/pt unknown
- 2019-03-22 DK DK19386015.2T patent/DK3549576T3/da active
- 2019-03-22 HR HRP20230688TT patent/HRP20230688T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
LT3549576T (lt) | 2023-07-25 |
EP3549576B1 (fr) | 2023-06-07 |
ES2949782T3 (es) | 2023-10-03 |
MA49588B1 (fr) | 2023-08-31 |
HRP20230688T1 (hr) | 2023-10-13 |
EP3549576A1 (fr) | 2019-10-09 |
HUE062623T2 (hu) | 2023-11-28 |
RS64344B1 (sr) | 2023-08-31 |
PL3549576T3 (pl) | 2023-11-06 |
GR1009589B (el) | 2019-09-11 |
SI3549576T1 (sl) | 2023-11-30 |
SMT202300189T1 (it) | 2023-09-06 |
DK3549576T3 (da) | 2023-06-26 |
FI3549576T3 (fi) | 2023-06-21 |
PT3549576T (pt) | 2023-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3345613A4 (fr) | Composition pharmaceutique contenant, comme principe actif, une protéine de fusion dans laquelle un peptide pénétrant les tumeurs et un agent antiangiogenèse sont fusionnés, pour la prévention et le traitement du cancer ou de maladies associées à l'angiogenèse | |
EA201992570A1 (ru) | Составы на основе человеческих антител к rankl, а также способы их применения | |
MA43763A (fr) | Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'une infection vrs | |
MY192532A (en) | Liquid pharmaceutical composition | |
HRP20220011T1 (hr) | Nova stabilna formulacija za fxia protutijela | |
NZ702342A (en) | Pharmaceutical formulation | |
PH12014501985A1 (en) | Il-17 antibody formulation | |
EP4000609A4 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies osseuses | |
MA54522A (fr) | Composition pharmaceutique pour le traitement de l'hypertension artérielle pulmonaire | |
MA49588A (fr) | Composition pharmaceutique pour le traitement de l'anémie dans un récipient adapté, qui conserve les ingrédients actifs séparés selon une méthode scellée :complexe ferrique avec de la caséine n-acétyl-l-aspartique et folinate pentahydrate de calcium | |
MX2020005055A (es) | Emulsiones para el tratamiento de infecciones de mucosas. | |
WO2018124948A8 (fr) | Composition pharmaceutique aqueuse d'un anticorps monoclonal recombinant pour le facteur de nécrose tumorale (tnf) α | |
EP3777849A4 (fr) | Composition pharmaceutique, comprenant du polmacoxib et de la prégabaline, pour le traitement de la douleur | |
MX2021001361A (es) | Composicion liquida de fibrinogeno humano. | |
FR3005263B1 (fr) | Composition pharmaceutique ou dietetique liquide ou semi-liquide depourvue d'amertume contenant un sel d'arginine. | |
EP3366292A4 (fr) | Composition pour la prévention ou le traitement de l'obésité contenant de l'acide alpha-lipoïque et de la n-acétylcystéine en tant que substances actives | |
MA43352B1 (fr) | Protéine sans phénylalanine pour le traitement de la phénylcétonurie | |
CN104664404A (zh) | 含锌硒保健药 | |
RU2016130965A (ru) | Антисептический ветеринарный препарат | |
BR102015015988A8 (pt) | composição líquida a base de tadalafil, para tratamento de disfunção erétil, com aplicação em sistema de spray de aerossol | |
EP3863643A4 (fr) | Azd3355 (lesogaberan) pour le traitement et la prévention de la stéatohépatite non alcoolique (nash), de la fibrose hépatique et d'autres affections hépatiques | |
MA38912A1 (fr) | Formulations pharmaceutiques effervescentes pauvres en sodium | |
MA54692A (fr) | Composition pour l'agriculture anti-pathogènes liquide | |
EP3691665C0 (fr) | Composition pharmaceutique comprenant un probiotique et un prébiotique pour prévenir l'acquisition d'infections pharmacorésistantes ou les traiter | |
EP3416677A4 (fr) | Composition pharmaceutique comprenant hgh recombinant pour le traitement d'un déficit en hormone de croissance |